This compound is a pharmaceutical intermediate characterized by a triazine ring structure with an amino group and a thioxo group. Its primary significance lies in its use as a building block for the synthesis of other chemical entities.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 33509-43-2
2-(2-Nitrovinyl)thiophene
Pharmaceutical intermediate compound
4,4'-(6-Chloropyrimidine-2,4-diyl)dimorpholine
Pharmaceutical intermediate compound
N-(3-(2-(2-chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide
Pharmaceutical intermediate compound
4-(5-BROMO-3-CHLOROPYRIDIN-2-YL)MORPHOLINE
Pharmaceutical intermediate compound
1-Bromo-2-butyne
pharmaceutical intermediate
4-Methoxy-N-methyl-2-nitrobenzenamine
Pharmaceutical intermediate
(R)-methyl4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-(tert-butyldimethylsilyloxy)-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate-R28549
steroid intermediate for API synthesis
Methyl 6-bromo-2-naphthoate
pharmaceutical intermediate
4-amino-6-tert-butyl-3-sulfanylidene-2H-1,2,4-triazin-5-one
OFKAVNQBCRJBJE-UHFFFAOYSA-N
CC(C)(C)C1=NNC(=S)N(C1=O)N
—